|
Stockholders' Equity (Deficiency) (Narrative from 10K) (Details) (USD $)
|
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Dec. 31, 2012
|
|
| Stockholders Equity Deficiency Details Narrative | |||
| Offering costs | the Company raised $530,337 (net of offering costs of $184,663 and five-year warrants to purchase: (i) 100,000 common shares at $0.35 per share and (ii) 98,000 common shares at $0.50 per share.) from the sale of 20.43 Units (including 2,042,856 common shares and 1,021,432 warrants) under the offering | the Company raised $530,337 (net of offering costs of $184,663 and five-year warrants to purchase: (i) 100,000 common shares at $0.35 per share and (ii) 98,000 common shares at $0.50 per share.) from the sale of 20.43 Units (including 2,042,856 common shares and 1,021,432 warrants) under the offering | |
| Stock options granted | 646,333 | 6,777,967 | |
| Stock options granted exercise price | $ 473,200 | $ 1,895,000 | $ 0.35 |
| Stock options vested | $ 56,784 | $ 625,350 | $ 910,214 |
| Fair value of stock options granted to employees | 0 | 57,750 | 1,747,007 |
| Compensation expense | 117,847 | 8,354 | 252,057 |
| Unrecognized compensation costs related to nonvested share-based compensation | $ 921,606 | $ 980,898 | |
| Unrecognized compensation costs weighted average period | 1 year 4 months 24 days | 1 year 6 months | |
| Weighted-average grant-date fair value of options granted to employees | $ 0.12 | $ 0.13 | |
| X | ||||||||||
|
- Definition
Custom Element. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Custom Element. No definition available.
|
| X | ||||||||||
|
- Definition
Custom Element. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
As of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Description of the various rights, preferences, and privileges of the limited partners' ownership units including: redemption, conversion, liquidation, tax status of distribution per unit and the sharing in distributions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. No definition available.
|